Nurix Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2020 to Q1 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Nurix Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q1 2024.
  • Nurix Therapeutics, Inc. Operating Margin for the quarter ending February 29, 2024 was -195 %, a 55.9% increase year-over-year.
  • Nurix Therapeutics, Inc. annual Operating Margin for 2023 was -201 %, a 57.7% increase from 2022.
  • Nurix Therapeutics, Inc. annual Operating Margin for 2022 was -476 %, a 20.1% decline from 2021.
  • Nurix Therapeutics, Inc. annual Operating Margin for 2021 was -396 %, a 8.66% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.